CDK1 and CCNA2 have excellent performance in AUC value, sensitivity and specificity and have been identified as biomarkers in hepatoblastoma (32–35), so their functions and roles have been relatively clear. This evidence concerns the gene CCNA2 and hepatoblastoma.